Frequently Asked Questions

FAQs - Hazardous Drug Monitoring

What areas should be tested?

There are many areas that can potentially be contaminated with the antineoplastic and hormonal agents. It is important to check contamination levels in these frequently used areas.

USP 800 states:
Environmental wipe sampling for HD surface residue should be performed routinely (e.g., initially as a benchmark and at least every 6 months, or more often as needed, to verify containment). Surface wipe sampling should include:

  • Interior of the C-PEC and equipment contained within
  • Pass-through chambers
  • Surfaces in staging or work areas near the C-PEC
  • Areas adjacent to C-PECs (e.g., floors directly under C-PEC, staging, and dispensing area)
  • Areas immediately outside the HD buffer room or the C-SCA
  • Patient administration areas
When will I get the results?

Results of the wipe studies are issued via email within 5-7 business days from the date your samples are received in our lab. If you need expedited results or are working on a specific deadline, we are happy to help.

Order Today

To order ChemoGLO products, please email our sales group at orders@chemoglo.com or call 1-877-215-2705 ext. 2